Menicon announced that the operating structure for its fertility supplement business will be transferred. The announcement date was provided in a timely disclosure document, which also stated that further details will be disclosed in due course.
Menicon formally announced that the operating structure for its fertility supplement business will be transferred.
Specific details of the transfer, including the transferee, are expected to be disclosed in subsequent timely disclosure announcements.